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Background
Rhesus macaque challenge models to evaluate protection
are important in the search for an AIDS vaccine. Many
challenge protocols use high dose SIV to ensure infection
of all control animals after a single challenge. Many virus
variants are predicted to infect the animals under these
conditions, which is different than the majority of human
infections. It is important to identify both the infecting
virus swarm in the stock, and the transmitted and replicat-
ing virus, to better evaluate vaccine candidates. It is impor-
tant to develop macaque models predicting human
vaccination outcome.
Methods
We performed single genome amplification (SGA) to
identify the full env sequence or a fragment encompassing
the highly variable V1/V2 region from naive SIVmac251-
challenged animals using plasma from the acute and
chronic phase, as well as from the original SIVmac251
challenge stocks.
Results
The two closely related SIVmac251 stocks sequenced by
SGA showed great diversity of env sequences. Most
changes were within the V1/V2 region, known to be
immunodominant for SIV antibody responses. Despite
the stock diversity, only a very narrow selection of similar
envs were detected during the acute phase in 7 of 9 ani-
mals infected by atraumatic mucosal application. In con-
trast, multiple diverse env sequences were found in the
chronic phase, which can be traced back to the stock.
Conclusion
Multiple species cross the mucosal barrier and infect the
host during a high dose mucosal infection. Interestingly,
one or very few of these variants propagate early in the
acute phase, but other transmitted variants emerge to
prominence later. This may be the result of viral fitness,
competition, founder effects, or innate mechanisms.
These findings also suggest that estimating the number of
transmitted virus variants by analysis during the acute
phase is inaccurate, and evaluation of both acute and
chronic virus is critical to identify the transmitted variants.
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